Thinking of joining a study?

Register your interest

NCT04750148 | Completed | Cancer


Validation of the Two-minute Walk Test in an Oncology Setting
Sponsor:

Aline Reinmann

Information provided by (Responsible Party):

Aline Reinmann

Brief Summary:

The aim of this study is to assess the validity of the 2-minute walk test (2MWT) compared to the 6-minute walk test (TM6) for subjects with onco-hematological disease.

Condition or disease

Cancer

Intervention/treatment

6-minute walk test

2-minutes walk test

10-meters walk test

One leg stance test

Detailed Description:

Cancer and its treatments have an impact on the body as a whole. The analysis of the subject's physical capacity is essential to know the basic level of the subject pre-treatment, to evaluate progress following rehabilitation, to set goals to prevent decline in physical capacity or to evaluate changes in physical capacity at different stages of survival. The 6-minute walk test (6MWT) is frequently used in the clinic to assess the physical capacity of the subject in oncology. A variant of the 6MWT exists and has been little studied in an oncological context: the 2-minute walk test (2MWT). The 2MWT is performed in the same way as the 6MWT: the same instructions and the same test procedure. It offers the advantage of being less tiring for the test subjects and saves clinicians time. The 2MWT has been validated in the past for people with COPD or after cardiac surgery. To our knowledge, it has not been validated for cancer patients.

Study Type : Observational
Estimated Enrollment : 56 participants
Official Title: Assessment of Physical Ability in Oncology: a Validation Study of the Two-minute Walk Test
Actual Study Start Date : February 15, 2021
Estimated Primary Completion Date : March 31, 2021
Estimated Study Completion Date : March 31, 2021

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Criteria
Inclusion Criteria
  • Have an onco-hematologic disease
  • Have medical authorization from the patient's oncologist authorizing gait tests
  • Participate in the HUG rehabilitation program
  • Be able to give consent by signature
  • To be of legal age
  • Do not present pain when walking more than 2/10
  • Be able to walk with or without technical aids for a period of 6 minutes (as per patient's statement)
Exclusion Criteria
  • Suffer from heart problems
  • Bone metastases at risk of fracture
  • Osteoporosis at high risk of fracture
  • Unbalanced Hypertension (hypertension)
  • Not being able to carry out the walk tests in their entirety
  • Not being able to perform the gait tests for reasons related to the side effects of the treatments (anemia, undernutrition, vomiting, severe fatigue, risk of thrombocytopenia, pain).
  • Not being able to carry out the walking test because of a lack of understanding of the instructions or because of psychological problems.

Validation of the Two-minute Walk Test in an Oncology Setting

Location Details


Please Choose a site



Validation of the Two-minute Walk Test in an Oncology Setting

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


Not yet recruiting

Switzerland,

Geneva University Hospitals

Geneva, Switzerland, 1205

Loading...